Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|November 15, 1989
Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo immunotargetingS Pervez, S C Kirkland, A A Epenetos, et al.
British Journal of Cancer|April 16, 2002
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexesP Savage, P Cowburn, A Clayton, et al.
In Vivo (Athens, Greece)|March 1, 1995
Generation of monoclonal antibodies utilizing the host anti-idiotypic networkM N Hatzistilianou, G B Sivolapenko, N S Courtenay-Luck, et al.
Human Pathology|June 1, 1994
Genetically engineered antibodies for diagnostic pathologyR A Spooner, S Murray, G Rowlinson-Busza, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Localization of monoclonal antibody AUA1 and its F(ab')2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical studyS Pervez, A A Epenetos, W J Mooi, et al.
British Journal of Cancer|January 1, 1984
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphataseA A Epenetos, P Travers, K C Gatter, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Accumulation characteristics of human colon carcinomas after monoclonal antibody ex vivo perfusionE Löhde, P Schwarzendahl, H Schlicker, et al.
Cancer|February 1, 1994
Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancerA Maraveyas, D Snook, V Hird, et al.
Medicinski Pregled|January 1, 1993
Targeting of non-small cell lung cancer using HMFG1-99mTc monoclonal antibodiesS Pavlović, D Jovanović, G Radosavljević, et al.
The International Journal of Biological Markers|January 1, 1986
Serum levels of c-myc and c-ras oncogene products in normal subjects and in patients with neoplastic and non neoplastic conditionsB Dhokia, D Pectasides, A A Epenetos, et al.
Pageof 16